Klotho Neurosciences Inc. (KLTO)
NASDAQ: KLTO
· Real-Time Price · USD
1.12
-0.06 (-5.49%)
At close: Jul 03, 2025, 3:59 PM
-5.49% (1D)
| Bid | 1.05 |
| Market Cap | 36.4M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -5.48M |
| EPS (ttm) | -0.27 |
| PE Ratio (ttm) | -4.15 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 1.21 |
| Volume | 4,030,108 |
| Avg. Volume (20D) | 42,238,398 |
| Open | 1.21 |
| Previous Close | 1.19 |
| Day's Range | 1.06 - 1.22 |
| 52-Week Range | 0.11 - 3.91 |
| Beta | 0.14 |
About KLTO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol KLTO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for KLTO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 days ago
+56.92%
Klotho Neurosciences shares are trading higher aft...
Unlock content with
Pro Subscription
1 week ago
+20%
Klotho Neuroscience shares are trading higher after the company announced its partnership with Okinawa longevity experts to explore gene therapy for healthy aging.
